
A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
Keywords: 4HPC; 4-hydroperoxycyclophosphamide; CC3; cleaved caspase-3; CI; combination index; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EGFRvIII; constitutively active mutant form of the epidermal growth factor receptor; SMO; ND2:SmoA1 t